Source link : https://www.newshealth.biz/health-news/more-adhd-drug-production-psilocybin-vs-lexapro-addiction-a-chronic-brain-disease/
Amid ongoing shortages, the U.S. Drug Enforcement Administration is allowing 24% more production of Takeda Pharmaceuticals’ attention deficit-hyperactivity disorder (ADHD) drug lisdexamfetamine (Vyvanse) and its generics. (Reuters) Is a chain of psychiatric hospitals detaining its patients to maximize insurance payments? (New York Times) High-dose psilocybin yielded better treatment responses than placebo and escitalopram (Lexapro) in […]
Author : News Health
Publish date : 2024-09-04 18:15:07
Copyright for syndicated content belongs to the linked Source.
Categories